Abstract
Abnormalities in thyroid hormone metabolism are common in critically ill patients. However, it is not known if these patients are truly hypothyroid at tissue level. Erythrocyte zinc has been shown to be a tissue marker of thyroid hormone status. In this study we have measured the erythrocyte zinc in critically ill patients.
In this observational study we measured the zinc content of young erythrocytes in blood samples from 33 healthy subjects, 26 hypothyroid patients, four hyperthyroid patients, and 44 patients in the intensive care unit – 22 of these were admitted after a major surgical procedure (surgical group) and the other 22 patients had a variety of conditions (non-surgical group). Erythrocytes were separated according to age by centrifugation. Plasma thyroid hormone concentrations were abnormal in 70% of the critically ill group. Erythrocyte zinc was significantly lower in hyperthyroid patients and higher in hypothyroid patients. In the non-surgical patients, erythrocyte zinc of young cells (median 256μmol/L of cells) was significantly higher than (p<0.01) the corresponding cells in the healthy controls (202μmol/L of cells), whereas in the surgical group it was not different (197μmol/L of cells). We conclude that in non-surgical critically ill patients, erythrocyte zinc content is higher, suggesting that these patients may be hypothyroid at tissue level.
References
1. Chopra IJ. Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1995; 82: 329–34. 10.1210/jcem.82.2.3745Search in Google Scholar
2. LoPresti JS, Nicoloff JT. Thyroid response to critical illness. Contemporary endocrinology. In: Ober KP, editor. Endocrinology of critical disease. Totowa, New Jersey: Humana Press, 1997:155–73. Search in Google Scholar
3. Maldonado LS, Murata GH, Hershman JM, Braunstein GD. Do thyroid function tests independently predict survival in the critically ill? Thyroid 1992; 2: 119–23. 10.1089/thy.1992.2.119Search in Google Scholar
4. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, L'abbate A, et al. Low T 3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107: 708–11. 10.1161/01.CIR.0000048124.64204.3FSearch in Google Scholar
5. Mak YT, Chan EL, Chan A, Woo J, Swaminathan R. Free triiodothyronine in serum of acutely ill general medical patients: a prognostic indicator? Clin Chem 1992; 38: 414–5. 10.1093/clinchem/38.3.414Search in Google Scholar
6. Ray DC, Drummond GB, Wilkinson E, Beckett GJ. Admission tyrotrophin concentrations do not predict outcome in critical illness. Anaesthesia 1995; 50: 1022–5. 10.1111/j.1365-2044.1995.tb05943.xSearch in Google Scholar
7. Ekins R. Measurement of free hormones in blood. Endocr Rev 1990; 11: 5–46. 10.1210/edrv-11-1-5Search in Google Scholar
8. De Groot LJ. Dangerous dogmas in medicine: the non-thyroid illness syndrome. J Clin Endocrinol Metab 1999; 84: 151–64. 10.1210/jcem.84.1.5364Search in Google Scholar
9. Melmed S, Geola FL, Reed AW, Packary AE, Park J, Her-shaman JM. A comparison of methods for assessing thyroid function in non thyroidal illness. J Clin Endocrinol Metab 1982; 54: 300–6. 10.1210/jcem-54-2-300Search in Google Scholar
10. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlim S, Kaplan MM. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993; 42: 1102–8. 10.1016/0026-0495(93)90266-QSearch in Google Scholar
11. Brent GA, Hershman JM, Reed AW, Sasta A, Lieberman J. Serum angiotensin converting enzyme in severe non-thyroidal illness associated with low serum thyroxine concentration. Ann Intern Med 1986; 100: 680–3. 10.7326/0003-4819-100-5-680Search in Google Scholar PubMed
12. Seppel T, Becker A, Lippert F, Schlaghecke F. Serum sex hormone binding globulin and osteocalcin in systemic non-thyroidal illness associated with low thyroid hormone concentrations. J Clin Endocrinol Metab 1996; 8: 1663–5. Search in Google Scholar
13. Yoshida K, Kiso Y, Watanabe T, Kaisi K, Kaisi N, Fukazawa H, et al. Clinical utility of red blood cell carbonic anhydrase I and zinc concentrations in patients with thyroid diseases. Metabolism 1991; 40: 1048–51. 10.1016/0026-0495(91)90128-JSearch in Google Scholar
14. Swaminathan R, Segall WH, Chapman C, Morgan DB. Red blood cell composition in thyroid disease. Lancet 1976; 2: 1382–5. 10.1016/S0140-6736(76)91920-6Search in Google Scholar
15. Lao TT, Chin RK, Swaminathan R, Panesar NS, Cockram CS. Erythrocyte zinc in the differential diagnosis of hyperthyroidism in pregnancy: a preliminary report. Br Med J 1987; 294: 1064–5. 10.1136/bmj.294.6579.1064Search in Google Scholar
16. Chan AY, Mak YT, Shek CC, Swaminathan R. Changes in erythrocyte zinc in a case of transient thyrotoxicosis. Ann Clin Biochem 1991; 28: 524–5. 10.1177/000456329102800520Search in Google Scholar
17. Murphy JR. Influence of temperature and method of centrifugation on the separation of erythrocytes. J Lab Clin Med 1993; 82: 334–41. Search in Google Scholar
18. Arumanayagam M, MacDonald D, Cockram CS, Swaminathan R. The effect of hyperthyroidism on in vivo ageing of erythrocyte ouabain binding sites and intracellular sodium and potassium. J Clin Endocrinol Metab 1990; 71: 260–3. 10.1210/jcem-71-1-260Search in Google Scholar
19. Li PK, Lee JT, Li CS, Deshpande G. Improved method for determining erythrocyte creatine by the diacetyl-alpha-naphthol reaction: elimination of endogenous glutathione interference. Clin Chem 1982; 28: 92–6. 10.1093/clinchem/28.1.92Search in Google Scholar
20. Hambridge M. Biomarkers of trace mineral intake and status. Am J Clin Nutr 2003; 133: 9485–555. Search in Google Scholar
21. Mafra D, Cozzolino MF. Erythrocyte zinc and carbonic anhydrase levels in nondialyzed chronic kidney disease patients. Clin Biochem 2004; 37: 67–71. 10.1016/j.clinbiochem.2003.03.001Search in Google Scholar
22. Gorodetsky R, Fuks Z, Sulkes A, Ginsburg H, Weshler Z. Correlation of erythrocyte and plasma levels of zinc, copper, and iron with evidence of metastatic spread in cancer patients. Cancer 1985; 15: 779–87. 10.1002/1097-0142(19850215)55:4<779::AID-CNCR2820550416>3.0.CO;2-SSearch in Google Scholar
23. Frithz G, Ronquist G. Increased red cell content of Zn 2+ in essential hypertension. Acta Med Scand 1979; 205: 647–9. 10.1111/j.0954-6820.1979.tb06120.xSearch in Google Scholar
24. Bergomi M, Rovesti S, Vinceti M, Vivoli R, Caselgrandi E, Vivoli G. Zinc and copper status and blood pressure. J Trace Elem Med Biol 1997; 11: 166–9. 10.1016/S0946-672X(97)80047-8Search in Google Scholar
25. Hori H, Yosida K, Fukazawatl H, Kiso Y, Sayama N, Mori A, et al. Effects of thyroid hormones on carbonic anhydrase I gene expression in human erythroid cells. Thyroid 1998; 8: 525–31. 10.1089/thy.1998.8.525Search in Google Scholar
26. Klein I, Ojamaa, K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501–9. 10.1056/NEJM200102153440707Search in Google Scholar
27. Klemperer JD, Klein I, Gomez LL, Hehma RE, Ojama K, Thomas JS, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995; 333: 1522–7. 10.1056/NEJM199512073332302Search in Google Scholar
28. Beltendorf M, Schmidt KG, Grulich-Henn J, Ulme HE, Heintich UE. Triiodothyronine treatment in children after cardiac surgery: a double blind randomised, placebo-controlled study. Lancet 2000; 365: 529–34. 10.1016/S0140-6736(00)02576-9Search in Google Scholar
©2005 by Walter de Gruyter Berlin New York
